FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Douwe Pons

Research Profile

Disorders

Procedures

Coronary Balloon Angioplasty

Concepts & Ideas

Physiology

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Occupations

Epigenomics

Chemicals & Drugs

Geographic Areas

Netherlands

Co-author Network

Publications

TOP 3
Michael Etscheid; J W Jukema; herbert koenig; Lars Muhl; Douwe Pons; Sandip M Kanse
The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.
Sandrin C Bergheanu; Douwe Pons; Bas L van der Hoeven; Su-San Liem; Bob Siegerink; Martin J Schalij; Johanna van der Bom; J Wouter Jukema
The 5352 A allele of the pro-inflammatory caspase-1 gene predicts late-acquired stent malapposition in STEMI patients treated with sirolimus stents.
Stella Trompet; Anton J M de Craen; J Wouter Jukema; Douwe Pons; P Eline Slagboom; D Kremer; E L E M Bollen; Rudi G J Westendorp
Variation in the CBP gene involved in epigenetic control associates with cognitive function.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Douwe Pons (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Michael Etscheid; J W Jukema; herbert koenig; Lars Muhl; Douwe Pons; Sandip M Kanse
The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.
Thrombosis research 2012;130(6):935-41.
2011: Sandrin C Bergheanu; Douwe Pons; Bas L van der Hoeven; Su-San Liem; Bob Siegerink; Martin J Schalij; Johanna van der Bom; J Wouter Jukema
The 5352 A allele of the pro-inflammatory caspase-1 gene predicts late-acquired stent malapposition in STEMI patients treated with sirolimus stents.
Heart and vessels 2011;26(3):235-41.
2011: Stella Trompet; Anton J M de Craen; J Wouter Jukema; Douwe Pons; P Eline Slagboom; D Kremer; E L E M Bollen; Rudi G J Westendorp
Variation in the CBP gene involved in epigenetic control associates with cognitive function.
Neurobiology of aging 2011;32(3):549.e1-8.
2011: Stella Trompet; Jeffrey J W Verschuren; Rudi G J Westendorp; Aeilko H Zwinderman; Anton J M de Craen; Robbert J De Winter; Pieter A F M Doevendans; M Arfan Ikram; Sandip M Kanse; Douwe Pons; P Eline Slagboom; René A Tio; J Wouter Jukema
Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality.
Stroke research and treatment 2011;2011():424759.
2011: Douwe Pons; Stella Trompet; Anton J M de Craen; Peter E Thijssen; Paul H A Quax; Margreet R De Vries; Rutger J Wierda; Peter J van den Elsen; Pascalle S Monraats; Mark M Ewing; Bas Heijmans; P Eline Slagboom; Aeilko H Zwinderman; Pieter A Doevendans; René A Tio; Robbert J De Winter; Moniek P M de Maat; Olga A Iakoubova; Naveed Sattar; Jim Shepherd; Rudi G J Westendorp; J Wouter Jukema
Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies.
Heart (British Cardiac Society) 2011;97(2):143-50.
2010: Pascalle S Monraats; Yue Fang; Douwe Pons; Nuno M M Pires; Huibert A P Pols; Aeilko H Zwinderman; Moniek P M de Maat; Pieter Af Doevendans; Robbert J DeWinter; René A Tio; Johannes Waltenberger; Rune R Frants; Paul H A Quax; Arnoud van der Laarse; Ernst E van der Wall; André G Uitterlinden; J Wouter Jukema
Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention.
Expert opinion on therapeutic targets 2010;14(3):243-51.
2010: J J W Verschuren; M L Sampietro; Douwe Pons; S Trompet; M M Ewing; Paul H A Quax; Peter de Knijff; Aeilko H Zwinderman; Robbert J De Winter; René A Tio; Moniek P M de Maat; P A F M Doevendans; J Wouter Jukema
Matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: Is there still room for determining genetic variation of MMPs for assessment of an increased risk of restenosis?
Disease markers 2010;29(5):265-73.
2009: Sandrin Bergheanu; Douwe Pons; J Wouter Jukema; Barend L van der Hoeven; Su-San Liem; Jan P Vandenbroucke; Frits R Rosendaal; Saskia Le Cessie; Martin J Schalij; Johanna van der Bom
Myocardial infarction occurs with a similar 24 h pattern in the 4G/5G versions of plasminogen activator inhibitor-1.
Chronobiology international 2009;26(4):637-52.
2009: Douwe Pons; Florentine R de Vries; Peter J van den Elsen; Bastiaan T Heijmans; Paul H A Quax; J Wouter Jukema
Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease.
European heart journal 2009;30(3):266-77.
2009: Douwe Pons; Pascalle S Monraats; Aeilko H Zwinderman; Moniek P M de Maat; Pieter A F M Doevendans; Robbert J De Winter; René A Tio; Johannes Waltenberger; J Wouter Jukema
Metabolic background determines the importance of NOS3 polymorphisms in restenosis after percutaneous coronary intervention: A study in patients with and without the metabolic syndrome.
Disease markers 2009;26(2):75-83.
2008: Douwe Pons; J Wouter Jukema
Epigenetic histone acetylation modifiers in vascular remodelling - new targets for therapy in cardiovascular disease.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2008;16(1):30-2.
2007: Douwe Pons; Pascalle S Monraats; Moniek P M de Maat; Nuno M M Pires; Paul H A Quax; Bart J M van Vlijmen; Frits R Rosendaal; Aeilko H Zwinderman; Pieter A Doevendans; Johannes Waltenberger; Robbert J De Winter; René A Tio; Rune R Frants; Arnoud van der Laarse; Ernst E van der Wall; J Wouter Jukema
The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions.
Thrombosis and haemostasis 2007;98(6):1323-8.
2007: S Trompet; Douwe Pons; Anton J M de Craen; P Eline Slagboom; James Shepherd; Gerard J Blauw; Michael B. Murphy; Stuart M Cobbe; E L E M Bollen; Brendan M Buckley; Ian Ford; Michael Hyland; Allan Gaw; Peter W Macfarlane; Chris J Packard; John Norrie; Ivan J Perry; David J Stott; Brian J Sweeney; Cillian Twomey; Rudi G J Westendorp; J Wouter Jukema
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study.
Annals of the New York Academy of Sciences 2007;1100():189-98.
2007: Pascalle S Monraats; F A S Kurreeman; Douwe Pons; V D K D Sewgobind; F R de Vries; Aeilko H Zwinderman; Moniek P M de Maat; Pieter A Doevendans; Robbert J De Winter; René A Tio; Johannes Waltenberger; Tom W J Huizinga; Daniel Eefting; Paul H A Quax; Rune R Frants; Arnoud van der Laarse; Ernst E van der Wall; J Wouter Jukema
Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.
Genes and immunity 2007;8(1):44-50.
2006: Pascalle S Monraats; Florentine de Vries; Laura W de Jong; Douwe Pons; Varsha D K D Sewgobind; Aeilko H Zwinderman; Moniek P M de Maat; Leen M 't Hart; Pieter A Doevendans; Robbert J De Winter; René A Tio; Johannes Waltenberger; Rune R Frants; Arnoud van der Laarse; Ernst E van der Wall; J Wouter Jukema
Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention.
Pharmacogenetics and genomics 2006;16(10):747-54.
2003: Josephine de Kluijver; Katrien Grunberg; Douwe Pons; E P A de Klerk; Claire R Dick; Peter J Sterk; Pieter S Hiemstra
Interleukin-1beta and interleukin-1ra levels in nasal lavages during experimental rhinovirus infection in asthmatic and non-asthmatic subjects.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2003;33(10):1415-8.